This is a non-core endpoint: only basic statistics are computed.
Transitory neonatal disorders of calcium and magnesium metabolism
P16_TRANSITO_NEONTAL_DISORD_CALCIUM_MAGNES_METABOLISM
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
5 |
4. Check minimum number of eventsNone |
5 |
5. Include endpointsNone |
5 |
6. Filter based on genotype QC (FinnGen only) |
5 |
Control definitions (FinnGen only)
- Control exclude
- P16_TRANSITO_ENDOCR_METABOLIC_DISORD_SPECIFIC_FETUS_NEWBO
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- P7[0-4]
- Name in latin
- Perturbationes transitoriae neonatales metabolismi calcii et magnesii
Similar endpoints
↥List of similar endpoints to
Transitory neonatal disorders of calcium and magnesium metabolism
based on the number of shared cases.
Similar with more cases:
- Transitory endocrine and metabolic disorders specific to fetus and newborn
- Certain conditions originating in the perinatal period
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥FinnGen case counts by registry codes:
Not enough data for upset plot.
Not enough data for upset table.
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1025 | 374 | 651 |
| Only index persons | 751 | 273 | 478 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.02 | 0.01 | 0.02 |
| Only index persons | 0.02 | 0.01 | 0.02 |
| Median age at first event (years) | |||
| Whole population | - | 0.00 | 0.00 |
| Only index persons | 0.00 | 0.00 | 0.00 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 5 | - | - |
| Unadjusted period prevalence (%) | 0.00 | - | - |
| Median age at first event (years) | 0.00 | - | - |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3021447) Carbon dioxide [Partial pressure] in Venous blood
0
14
0.00
0.50
0.0
18.6
—
6.0
—
0
14
(3024354) Oxygen [Partial pressure] in Venous blood
0
14
0.00
0.50
0.0
18.6
—
5.2
—
0
14
(3012544) pH of Venous blood
0
14
0.00
0.50
0.0
18.6
—
—
—
0
0
(3044889) 12 lead EKG panel
0
13
0.00
0.49
0.0
2.5
—
—
—
0
0
(3000991) Gas panel - Venous blood
0
13
0.00
0.49
0.0
13.9
—
—
—
0
0
(3015736) pH of Urine
0
11
0.00
0.24
0.0
4.6
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
0
11
0.00
0.24
0.0
12.9
—
29.5
—
0
11
(3011397) Hemoglobin [Presence] in Urine by Test strip
0
10
0.00
0.24
0.0
4.0
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
0
10
0.00
0.24
0.0
6.0
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
0
10
0.00
0.24
0.0
1.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
0
12
0.00
0.24
0.0
2.7
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
0
9
0.00
0.24
0.0
2.8
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
0
6
0.00
0.00
0.0
3.5
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
39.2
—
4.5
—
0
5
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
20.0
—
0.9
—
0
6
(3017732) Neutrophils [#/volume] in Blood
0
5
0.00
0.00
0.0
1.4
—
3.9
—
0
5
(3018677) aPTT in Platelet poor plasma by Coagulation assay
0
7
0.00
0.00
0.0
32.0
—
35.7
—
0
7
(1001926) Buprenorphine [Presence] in Urine by Screen method
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
0
6
0.00
0.00
0.0
20.2
—
204.3
—
0
6
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
0
7
0.00
0.00
0.0
1.6
—
102.6
—
0
7
(3019832) Treponema pallidum Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3036489) Thrombin time
0
6
0.00
0.00
0.0
20.3
—
24.0
—
0
6
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
0
6
0.00
0.00
0.0
7.8
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
16.5
—
103.0
—
0
6
(3003327) Ova and parasites identified in Stool by Light microscopy
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
38.2
—
0.9
—
0
5
(3048929) Epstein Barr virus Ab [Presence] in Serum
0
7
0.00
0.00
0.0
2.4
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
0
5
0.00
0.00
0.0
17.8
—
1.1
—
0
5
(3028707) Methadone [Presence] in Urine by Screen method
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
0
8
0.00
0.00
0.0
6.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
0
6
0.00
0.00
0.0
20.7
—
2.4
—
0
6
(3027944) Amphetamines [Presence] in Urine
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.4
—
25.4
—
0
5
(3000764) Benzodiazepines [Presence] in Urine
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
197.8
—
0
5
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
0
5
0.00
0.00
0.0
25.6
—
92.0
—
0
5
Mortality – FinRegistry
↥Association
Association between endpoint P16_TRANSITO_NEONTAL_DISORD_CALCIUM_MAGNES_METABOLISM and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have P16_TRANSITO_NEONTAL_DISORD_CALCIUM_MAGNES_METABOLISM.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: P16_TRANSITO_NEONTAL_DISORD_CALCIUM_MAGNES_METABOLISM – Transitory neonatal disorders of calcium and magnesium metabolism
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data